REGENERON PHARMACEUTICALS (REGN)       745.42  +9.19 (+1.25%)

745.42  +9.19 (+1.25%)

US75886F1075 - Common Stock

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 11.14 9.67 1.4715.25% Q2 2022 9.77 9.02 0.758.33% Q1 2022 8.93 9.93 -1.00-10.09% Q4 2021 21.32 18.71 2.6113.93% Q3 2021 14.37 10.31 4.0639.43% Q2 2021 25.80 17.88 7.9244.32% Q1 2021 9.89 9.18 0.717.72% Q4 2020 9.53 8.56 0.9711.32%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 41.92 71.38 -41.28%Q4 2022 10.87 21.32 -49.02%FY 2023 44.05 41.92 5.09%Q1 2023 10.63 8.93 19.00%Q2 2023 11.22 9.77 14.82%Q3 2023 11.02 11.14 -1.08%Q4 2023 10.67 10.87 -1.87%FY 2024 46.67 44.05 5.96%Q1 2024 10.92 10.63 2.80%Q2 2024 10.28 11.22 -8.35%Q3 2024 11.44 11.02 3.86%Q4 2024 10.57 10.67 -0.92%FY 2025 48.29 46.67 3.46%FY 2026 50.96 48.29 5.53%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 2.936B 2.926B 10.2M0.35% Q2 2022 2.857B 2.852B 5.2M0.18% Q1 2022 2.965B 2.779B 186.1M6.70% Q4 2021 4.952B 4.598B 353.7M7.69% Q3 2021 3.453B 2.873B 579.8M20.18% Q2 2021 5.139B 3.995B 1.144B28.62% Q1 2021 2.529B 2.602B -73.3M-2.82% Q4 2020 2.423B 2.471B -48.1M-1.95%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 12.14B 16.072B -24.46%Q4 2022 3.282B 4.952B -33.72%FY 2023 12.91B 12.14B 6.34%Q1 2023 3.025B 2.965B 2.02%Q2 2023 3.111B 2.857B 8.88%Q3 2023 3.168B 2.936B 7.89%Q4 2023 3.327B 3.282B 1.37%FY 2024 13.649B 12.91B 5.72%Q1 2024 2.821B 3.025B -6.74%Q2 2024 2.75B 3.111B -11.60%Q3 2024 2.935B 3.168B -7.35%Q4 2024 2.866B 3.327B -13.86%FY 2025 13.785B 13.649B 1.00%FY 2026 13.951B 13.785B 1.20%